Series – Page 4 – media

Codiak BioSciences Closes $76.5 Million Series C Financing

Codiak intends to use the proceeds of the Series C financing to advance its initial product candidates into clinical trials, and to continue to develop the company's transformational exosome therapeutic platform.
- Source: Businessinsider
- 131
- November 30, 2017
Clinical Trials exosome therapeutic Market Views Series
Doctolib raises another $42 million for its medical care scheduling service

French startup Doctolib is raising money for the second time in the past twelve months. The company is building a sort of Salesforce for the healthcare industry with a big emphasis on bookings. Doctolib just raised $42 million (€35 million) from Eurazeo and existing investor Bpifrance.
- Source: Technologythrill
- 90
- November 29, 2017
Doctolib Market Views Series
Bay Area’s Medeor Therapeutics Bags $57M

Medeor Therapeutics announced it had closed on an oversubscribed Series B financing worth $57 million. The round was led by RA Capital Management. New investors included Sofinnova Ventures and 6 Dimensions Capital. They were joined by existing investors Vivo Capital and WuXi Healthcare Ventures.
- Source: Biospace
- 165
- November 28, 2017
cellular immunotherapies Market Views Series
Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic

Amgen’s VC wing has invested in Fortuna Fix to help move autologous neural stem cells into the clinic. The $25 million series B sets regenerative medicine startup Fortuna up to move candidates against Parkinson’s disease and spinal cord injury to clinical trials next year.
- Source: Fiercebiotech
- 87
- November 14, 2017
Amgen autologous neural stem cells Series
Genetic testing startup Prenetics raised $40M in Series B round led by Alibaba’s Hong Kong fund and Beyond Ventures

Genetic testing startup Prenetics has raised $40 million in a Series B funding round led by Hong Kong-based venture capital fund Beyond Ventures and the Alibaba Hong Kong Entrepreneurs Fund.
- Source: Mastsea
- 186
- October 19, 2017
Artificial Intelligence Market Views Series
Medical Monitoring Device Maker MagicMed Bags USD1.5 Million in Pre-Series A Financing

Medical equipment maker MagicMed Technologies (Beijing) Co. has secured USD1.5 million (CNY10 million) in pre-series A financing. The funds will help the firm hasten the commercialization of its Magitor Cell, a single channel electrocardiographic monitoring device.
- Source: Yicaiglobal
- 114
- October 18, 2017
MagicMed Technologies Magitor Cell Series
InflaRx announces a $ 55M Series D financing and investment round

InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced a $ 55M Series D financing and investment round.
- Source: inflarx.de
- 170
- October 17, 2017
Market Views Series therapeutics
Cardiologs raises $6m in Series A to support ECG Analysis Platform

Cardiologs Technologies said this week it raised $6.4 million in a Series A round of financing to support accelerated commercialization of its Cardiologs ECG Analysis Platform in the US and Europe.
- Source: Massdevice
- 121
- October 10, 2017
Cardiologs Market Views Series
Two Scientists Nab Another $20 Million for Their CRISPR Biotech Eligo Bioscience

Eligo Bioscience, the French microbiome company developing drugs to prevent and treat bacteria-associated diseases, has secured a $20 million Series A round of financing from Khosla Ventures and Seventure Partners, including a $2 million award from the Worldwide Innovation Challenge. This comes just months after Eligo was selected as one of the 30 Most Innovative Companies in 2017 by the World Economic Forum. This funding will enable Eligo to strengthen its biotherapeutic platform, begin clinical trials for its lead indication and extensively grow its international team of scientists, engineers, and executives.
- Source: Biospace
- 193
- September 29, 2017
Market Views microbiome Series
Pfizer launches upstart with $103M, phase 3-ready drugs

In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup.
- Source: Fiercebiotech
- 129
- September 27, 2017
Clinical Trials Pfizer Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

Ddu’s International Medical Exhibition Attendance Delivering High Results.

April 9, 2018
Medtec China 2018 scale will grow by 10% to feed the rapidly growing needs of the medical device industry in China

March 8, 2018
Ddu Attended Arab Health A Perfect Match for International Trade

March 2, 2018
Gulf Dentex 2018, will be held in October from 20th to 22nd in ADNEC in Abu Dhabi

March 2, 2018

Market Reportsmore

China’s Import and Export Market Report of Contraceptive Drugs

March 16, 2018
Ddu College — China’s Import and Export Report of Peptic Ulcer Drugs

January 25, 2018
China’s Import and Export Report of External Use Otology Drugs

January 12, 2018
Ddu College–China’s Import and Export Market Report of Antiallergic Drugs

December 1, 2017

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.